Core Viewpoint - The Ministry of Commerce and eight other departments have issued opinions to promote the high-quality development of the pharmaceutical retail industry, aiming to transform it into a "health station" that meets the medical and health needs of the public [1][6]. Group 1: Overall Requirements - The opinions emphasize the need for a combination of government guidance and market leadership, focusing on innovation and standardized development to enhance the internal driving force and market vitality [6]. Group 2: Improving Pharmaceutical Services - The opinions propose 18 specific measures to enhance pharmaceutical services, including allowing retail chain enterprises to establish their own pharmaceutical service platforms and supporting free or subsidized continuing education for pharmacists [3][4]. - Encouragement for retail enterprises to build electronic prescription platforms and participate in centralized drug procurement [7][9]. Group 3: Innovating Health Services - Retail enterprises are encouraged to expand health management services, including drug guidance and health consultations, and to collaborate with community organizations for health care services [10]. - The development of digital and intelligent health service policies is promoted to enhance service experiences [10]. Group 4: Strengthening Emergency Services - Large retail chains are encouraged to establish dynamic demand forecasting and low inventory warning mechanisms to enhance their emergency supply capabilities [12]. - Retail pharmacies are urged to participate in monitoring key drug markets and provide services during emergencies [12]. Group 5: Optimizing Industry Structure - The opinions support mergers and acquisitions among retail pharmacies and encourage the integration of wholesale and retail operations to improve supply chain efficiency [13][14]. - The establishment of a fair pricing system for drugs is advocated to promote healthy competition in the retail sector [14]. Group 6: Regulating Industry Order - The development of smart regulation is emphasized, with a focus on accurate data collection and risk-based management of retail pharmacies [14]. - Strengthening self-discipline within the industry and establishing a mechanism to penalize severely untrustworthy enterprises is highlighted [14].